Manufactured by Grifols Biologicals, Inc. (MCE: GRF), Antihemophilic Factor/von Willebrand Factor Complex (Human) – Alphanate – has recently been approved by the USFDA for patients undergoing surgery or invasive procedures with von Willebrand disease (vWD), when the hormone desmopressin is either ineffective or contraindicated.
The product is however not approved for patients with severe vWD (type 3) who are undergoing major surgery.
Already approved for the prevention and control of bleeding in patients with Factor VIII deficiency due to hemophilia A or acquired Factor VIII deficiency, Alphanate is the first biologic product approved for treatment of surgical and invasive procedures in patients with vWD.
Alphanate is purified from pooled human plasma from carefully screened and tested U.S. donors, and contains the clotting proteins deficient or defective in vWD, which are Factor VIII (also known as Antihemophilic factor) and von Willebrand factor.
vWD is the most common inherited bleeding disorder caused by a deficiency or defect in certain plasma proteins critical to blood clotting.
Source: FDA News, Grifols press room
hi. my name is Gansukh Battulga. i am from mongolia. my brother is 15. he is live in mongolia now. he is hemophilia B. he can't find antihemophilic factor in the Mongolia. he is dieing. i want to send antihemophilic factor to mongolia. can you help me? tell me what can i do? PLEASE.
Posted by: ganaa | August 19, 2007 8:47 AM | Permalink to Comment